FC
WST icon

Farringdon Capital’s West Pharmaceutical WST Stock Holding History

Farringdon Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$242K Buy
+966
New +$240K 0.05% 323
2025
Q4 		– Sell
-799
Closed -$210K – 665
2025
Q3 		$210K Sell
799
-265
-25% -$64.4K 0.05% 396
2025
Q2 		$233K Buy
+1,064
New +$227K 0.08% 380

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Farringdon Capital's WST Position: Q1 2026 in Review

Farringdon Capital opened a new position in West Pharmaceutical (WST) in Q1 2026: 966 shares worth $242K. The stake represents 0.05% of the portfolio and ranks #323 among its holdings. This is a return to the name: Farringdon Capital previously reported a position in WST as recently as Q3 2025.

Farringdon Capital first reported a position in WST in Q2 2025 and has held it in 3 quarters since. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Farringdon Capital held 966 shares of West Pharmaceutical worth $242K as of Q1 2026.
  • West Pharmaceutical was a new Farringdon Capital position in Q1 2026.
  • West Pharmaceutical made up 0.05% of Farringdon Capital's portfolio in Q1 2026, its #323 holding.
  • Farringdon Capital first reported a position in West Pharmaceutical in Q2 2025 and has held it in 3 quarters since.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Farringdon Capital's 13F filing for Q1 2026, filed 15 May 2026.